Sign In
Buy CCXI
$13.86
-0.140 (-1.00%)
At Close: Jul 31, 2026
RADNOR, Pa., May 18, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds ChemoCentryx, Inc. (NASDAQ: CCXI) ("ChemoCentryx") investors that a securities fraud class actio
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ChemoCentryx, Inc. - CCXI
05:40am, Tuesday, 18'th May 2021
NEW YORK, May 18, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ChemoCentryx, Inc. ("ChemoCentryx" or the "Company") (NASDAQ: CCXI). Such investors are adv
San Francisco, California--(Newsfile Corp. - May 17, 2021) - Hagens Berman urges ChemoCentryx, Inc. (NASDAQ: CCXI) investors with significant losses to submit your losses now. A securities fraud class
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming July 6, 2021 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purc
NEW YORK--(BUSINESS WIRE)-- #CCXI--Scott+Scott Attorneys at Law LLP Alerts Investors to Securities Class Action Against ChemoCentryx, Inc. (CCXI) and July 6 Deadline
New York, New York--(Newsfile Corp. - May 15, 2021) - WHY:Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of
CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds ChemoCentryx, Inc. Shareholders of Securities Fraud Class Action Lawsuit
09:30am, Saturday, 15'th May 2021
Radnor, Pennsylvania--(Newsfile Corp. - May 15, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds against ChemoCentryx, Inc. (NASDAQ: CCXI) ("ChemoCentryx") investors that a securitie
New Orleans, Louisiana--(Newsfile Corp. - May 13, 2021) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have un
CCXI INVESTORS ACT NOW: Contact Hagens Berman, National Trial Attorneys, to Recover Losses Due to Alleged Securities Fraud
01:40pm, Thursday, 13'th May 2021
San Francisco, California--(Newsfile Corp. - May 13, 2021) - Hagens Berman urges ChemoCentryx, Inc. (NASDAQ: CCXI) investors with significant losses to submit your losses now. A securities fraud class
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against ChemoCentryx, Inc. (CCXI)
11:00am, Thursday, 13'th May 2021
LOS ANGELES--(BUSINESS WIRE)---- $CCXI #CLASSACTION--Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming July 6, 2021 deadline to file a lead plaintiff motion in the class action
RADNOR, Pa., May 12, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors that a securities fraud class action lawsuit has been filed against ChemoCentryx, Inc. (
New York, New York--(Newsfile Corp. - May 12, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Che
New York, New York--(Newsfile Corp. - May 12, 2021) - The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders of ChemoCentryx, Inc.Shareholders w
CCXI LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving ChemoCentryx, Inc.
02:28pm, Wednesday, 12'th May 2021
New York, New York--(Newsfile Corp. - May 12, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased ChemoCentryx, Inc.
Lost Money in ChemoCentryx, Inc.?
02:12pm, Wednesday, 12'th May 2021
OAKLAND, Calif.--(BUSINESS WIRE)---- $CCXI #CCXI--Gibbs Law Group LLP investigates potential legal claims on behalf of ChemoCentryx investors.
